BCL2L1 and Merkel cell skin cancer: ABT-263 is a Bcl-2 family inhibitor that binds to Bcl-2, Bcl-xL, and Bcl-w, disrupting their interaction with proapoptotic proteins and inducing apoptosis in MCC cells [93].